Subtopic Deep Dive
GDF15 in Obesity and Metabolism
Research Guide
What is GDF15 in Obesity and Metabolism?
GDF15 in Obesity and Metabolism examines the cytokine's role in suppressing appetite, reducing body weight, and improving glucose tolerance through GFRAL receptor signaling in obesity models.
GDF15, also known as MIC-1, acts as a myomitokine and anorexigenic factor elevated in obesity to regulate energy homeostasis (Chung et al., 2016, 337 citations). Studies demonstrate GDF15 decreases food intake and body weight in mice on normal and obesogenic diets (Macia et al., 2012, 203 citations). Physiological levels of MIC-1/GDF15 regulate appetite via brain feeding centers (Tsai et al., 2013, 186 citations). Over 10 papers from the list address these mechanisms.
Why It Matters
GDF15 suppression of appetite positions it as a therapeutic target for obesity and type 2 diabetes, with metformin inducing GDF15 to improve glucose tolerance (Macia et al., 2012; Tsai et al., 2013). In obesogenic diets, GDF15 reduces body weight and enhances metabolic outcomes, relevant to global epidemics (Chung et al., 2016). Elevated GDF15 links to adipose inflammation and energy homeostasis, informing drug development (Ren et al., 2022). Cancer cachexia studies highlight GDF15's catabolic role extendable to obesity interventions (Setiawan et al., 2023).
Key Research Challenges
Translating Mouse Models
Mouse studies show GDF15 reduces food intake on obesogenic diets, but human translation faces species differences in GFRAL signaling (Macia et al., 2012). Lack of human trial data limits clinical application (Tsai et al., 2013).
Metformin Induction Specificity
Metformin elevates GDF15 for glucose benefits, yet isolating this pathway from other effects remains unresolved (Mohammed et al., 2021). Mechanisms linking metformin to GDF15 in obesity need clarification.
Gut-Brain Axis Integration
GDF15's anorexigenic effects via gut-brain signaling require better integration with myokine roles in energy homeostasis (Chung et al., 2016). Inflammation modulation in adipose tissue complicates signaling (Ren et al., 2022).
Essential Papers
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Jörg Wischhusen, Ignacio Melero, Wolf H. Fridman · 2020 · Frontiers in Immunology · 452 citations
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a divergent member of the transforming growth factor β superfamily. While physiological expression is bare...
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
Hyo Kyun Chung, Dongryeol Ryu, Koon Soon Kim et al. · 2016 · The Journal of Cell Biology · 337 citations
Reduced mitochondrial electron transport chain activity promotes longevity and improves energy homeostasis via cell-autonomous and –non-autonomous factors in multiple model systems. This mitohormet...
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine Webster, Laura JAP Kempen, Rowan Hardy et al. · 2020 · Frontiers in Physiology · 305 citations
Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no specific ...
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup
Jamie N. Justice, Luigi Ferrucci, Anne B. Newman et al. · 2018 · GeroScience · 301 citations
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding et al. · 2021 · Frontiers in Endocrinology · 248 citations
The numerous beneficial health outcomes associated with the use of metformin to treat patients with type 2 diabetes (T2DM), together with data from pre-clinical studies in animals including the nem...
Cancer cachexia: molecular mechanisms and treatment strategies
Tania Setiawan, Ita Novita Sari, Yoseph Toni Wijaya et al. · 2023 · Journal of Hematology & Oncology · 217 citations
Abstract Muscle wasting is a consequence of physiological changes or a pathology characterized by increased catabolic activity that leads to progressive loss of skeletal muscle mass and strength. N...
Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets
Laurence Macia, Vicky Wang-Wei Tsai, Amy Nguyen et al. · 2012 · PLoS ONE · 203 citations
Food intake and body weight are controlled by a variety of central and peripheral factors, but the exact mechanisms behind these processes are still not fully understood. Here we show that that mac...
Reading Guide
Foundational Papers
Start with Macia et al. (2012, 203 citations) for direct evidence of GDF15 reducing food intake and weight in obesogenic mice, followed by Tsai et al. (2013, 186 citations) for physiological appetite regulation mechanisms.
Recent Advances
Study Chung et al. (2016, 337 citations) for myomitokine energy homeostasis; Ren et al. (2022, 186 citations) for adipose inflammation links; Mohammed et al. (2021, 248 citations) for metformin induction.
Core Methods
Mouse GDF15 overexpression or injection with food intake monitoring (Macia et al., 2012); transcriptomics for mitochondrial stress (Chung et al., 2016); ELISA for circulating levels in obesity models (Tsai et al., 2013).
How PapersFlow Helps You Research GDF15 in Obesity and Metabolism
Discover & Search
Research Agent uses searchPapers with 'GDF15 obesity metabolism GFRAL' to retrieve Chung et al. (2016) as top hit (337 citations), then citationGraph reveals Macia et al. (2012) and Tsai et al. (2013) as key foundational works, while findSimilarPapers expands to Ren et al. (2022) on adipokines.
Analyze & Verify
Analysis Agent applies readPaperContent to extract GDF15 dosage effects from Macia et al. (2012), verifies claims with verifyResponse (CoVe) against Tsai et al. (2013), and uses runPythonAnalysis to plot weight loss data from multiple papers with pandas for statistical correlation (p<0.05), graded via GRADE as high-evidence for mouse models.
Synthesize & Write
Synthesis Agent detects gaps like human trial scarcity post-Chung et al. (2016), flags contradictions in cachexia vs. obesity roles, then Writing Agent uses latexEditText for figure captions, latexSyncCitations for 10+ references, and latexCompile to generate a review manuscript with exportMermaid for GDF15-GFRAL signaling diagrams.
Use Cases
"Extract and analyze GDF15 weight loss data from mouse obesity studies"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot of body weight from Macia et al. 2012 vs. controls) → statistical output with correlation coefficients.
"Write LaTeX section on GDF15 mechanisms in metabolism with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Chung 2016, Tsai 2013) + latexCompile → formatted PDF section ready for submission.
"Find code for GDF15 expression analysis in obesity datasets"
Research Agent → paperExtractUrls (from Chung et al. 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for qPCR normalization in metabolic tissues.
Automated Workflows
Deep Research workflow scans 50+ GDF15 papers via searchPapers, structures report on obesity mechanisms with GRADE grading prioritizing Macia et al. (2012). DeepScan applies 7-step analysis: citationGraph → readPaperContent → runPythonAnalysis on Chung et al. (2016) data → CoVe verification. Theorizer generates hypotheses on metformin-GDF15 synergies from Mohammed et al. (2021) and Tsai et al. (2013).
Frequently Asked Questions
What is the definition of GDF15's role in obesity?
GDF15 acts as an anorexigenic cytokine suppressing appetite and reducing body weight via GFRAL in obesity models (Macia et al., 2012).
What methods study GDF15 in metabolism?
Mouse models on obesogenic diets measure food intake and glucose tolerance post-GDF15 administration (Tsai et al., 2013); myokine assays link to mitochondrial stress (Chung et al., 2016).
What are key papers on GDF15 obesity effects?
Chung et al. (2016, 337 citations) on myomitokine role; Macia et al. (2012, 203 citations) on weight loss in mice; Tsai et al. (2013, 186 citations) on physiological regulation.
What open problems exist in GDF15 obesity research?
Human trials lacking for GFRAL agonists; unclear metformin-GDF15 specificity; integrating gut-brain-myokine axes (Mohammed et al., 2021; Ren et al., 2022).
Research GDF15 and Related Biomarkers with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GDF15 in Obesity and Metabolism with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the GDF15 and Related Biomarkers Research Guide